Back
Hyliion Holdings 10K Form
Sell
31
HYLN
Hyliion Holdings
Last Price:
2.54
Seasonality Move:
11.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-05-17 | 10K | HYLN/Hyliion Holdings Annual |
2021-02-26 | 10K | HYLN/Hyliion Holdings Annual |
2020-11-12 | 10Q | HYLN/Hyliion Holdings Quarterly |
2020-08-06 | 10Q | HYLN/Hyliion Holdings Quarterly |
2020-05-07 | 10Q | HYLN/Hyliion Holdings Quarterly |
2020-03-23 | 10K | HYLN/Hyliion Holdings Annual |
Receive HYLN News And Ratings
See the #1 stock for the next 7 days that we like better than HYLN
HYLN Financial Statistics
Sales & Book Value
Annual Sales: | $672K |
---|---|
Cash Flow: | $-15.93M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.54 |
Price / Book: | 1.65 |
Profitability
EPS (TTM): | -0.48000 |
---|---|
Net Income (TTM): | $-85.9M |
Gross Margin: | $-1.04M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Hyliion Holdings Earnings Forecast
Key Hyliion Holdings Financial Ratios
- The Gross Profit Margin over the past 5 years for HYLN is -155.36%.
- The Selling, General & Administrative Expenses for HYLN have been equal to 6,340.92% of Gross Profit Margin.
- The Research & Development expenses have been 12,238.10% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of HYLN is -18,379.46% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Hyliion Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | HYLN |
CUSIP: | 449109 |
Website: | hyliion.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
HYLN Technical Analysis vs Fundamental Analysis
Sell
31
Hyliion Holdings (HYLN)
is a Sell
Is Hyliion Holdings a Buy or a Sell?
-
Hyliion Holdings stock is rated a Sell
The current Hyliion Holdings [HYLN] share price is $2.54. The Score for HYLN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.